Zacks Research Weighs in on Henry Schein, Inc.’s Q3 2025 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Zacks Research lowered their Q3 2025 earnings per share estimates for Henry Schein in a research note issued to investors on Monday, July 29th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.43 for the quarter, down from their previous estimate of $1.44. The consensus estimate for Henry Schein’s current full-year earnings is $5.16 per share.

Several other analysts have also recently commented on HSIC. Robert W. Baird raised shares of Henry Schein from a “neutral” rating to an “outperform” rating and lifted their target price for the stock from $81.00 to $92.00 in a research note on Monday, July 22nd. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Barrington Research reiterated an “outperform” rating and set a $92.00 target price on shares of Henry Schein in a research report on Friday, July 5th. Piper Sandler restated an “overweight” rating and issued a $86.00 price target on shares of Henry Schein in a report on Friday, June 21st. Finally, Evercore ISI dropped their price objective on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research note on Tuesday, July 9th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Henry Schein has a consensus rating of “Moderate Buy” and an average price target of $81.67.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $71.94 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The firm has a market cap of $9.21 billion, a PE ratio of 24.30, a P/E/G ratio of 1.79 and a beta of 0.87. The firm has a 50 day simple moving average of $68.03 and a 200-day simple moving average of $71.81. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.21 EPS.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of HSIC. Summit Securities Group LLC acquired a new stake in shares of Henry Schein in the second quarter worth $31,000. Beach Investment Counsel Inc. PA purchased a new stake in Henry Schein during the 2nd quarter worth $37,000. Blue Trust Inc. increased its holdings in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares in the last quarter. Mather Group LLC. raised its position in Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after purchasing an additional 216 shares during the period. Finally, Palisade Asset Management LLC acquired a new position in shares of Henry Schein during the first quarter worth about $113,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.